- Home
- SKIN
SKIN
The Beauty Health Company
as 06-20-2025 3:41pm EST
| Founded: | 1997 | Country: | United States |
| Employees: | N/A | City: | LONG BEACH |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $1.42 | AVG Volume (30 days): | 597.2K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.39 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.78 - $2.24 | Next Earning Date: | 08-07-2025 |
| Revenue: | $322,471,000 | Revenue Growth: | -17.97% |
| Revenue Growth (this year): | -11.43% | Revenue Growth (next year): | 5.72% |
Latest The Beauty Health Company News
SKIN Breaking Stock News: Dive into SKIN Ticker-Specific Updates for Smart Investing
GlobeNewswire
11 days ago
Hydrafacial Unveils New HydraFillic with Pep9™ Skin Booster For Fine Line & Wrinkles
GlobeNewswire
17 days ago
BeautyHealth Surpasses 35,000 Hydrafacial Devices Worldwide Reflecting Growing Consumer Demand for Clinically Proven Skin Health Treatments
GlobeNewswire
a month ago
The Beauty Health Company Announces Convertible Debt Refinancing
Simply Wall St.
a month ago
Beauty Health First Quarter 2025 Earnings: Beats Expectations
GuruFocus.com
a month ago
The Beauty Health Co (SKIN) Q1 2025 Earnings Call Highlights: Surpassing Revenue Expectations ...
GlobeNewswire
a month ago
BeautyHealth Reports First Quarter 2025 Financial Results
GuruFocus.com
a month ago
What To Expect From The Beauty Health Co (SKIN) Q1 2025 Earnings
Simply Wall St.
2 months ago
Spotlight On 3 Promising Penny Stocks With Market Caps Over $60M
Compare SKIN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SKIN The Beauty Health Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.